Tobacco quitlines can be operationally complex and services may vary a great deal depending on the goals and objectives of the quitline. IQI trainings expose attendees to state-of-the-art quitline processes and provide an interactive experience with experts who have operated quitlines for many years. The IQI provides a unique opportunity to network with quitline experts and peers from around the world with special attention to requirements of the World Health Organization (WHO) Framework Convention on Tobacco Control (FCTC) Article 14 and the MPOWER package.
The goal of the IQI, now in its fifth year, is to reduce the toll of the global tobacco epidemic by increasing access to, and utilization of, evidence-based tobacco cessation resources, with a focus on maximizing reach and effectiveness of treatment for smokers in low- and middle-income countries with a high prevalence of tobacco use and tobacco-related disease.
To this end, IQI conducts international training programs, and provides education, technical assistance, and other resources for tobacco quitline development, improvement, and integration with health care systems and overall tobacco control activities.
Funding is provided by Pfizer Independent Grants for Learning & Change through the UCSF Smoking Cessation Leadership Center, a Robert Wood Johnson Foundation program. Additional support for the IQI has come from Optum (formerly Alere Health and Free & Clear), the largest provider of quitline services in the world), the American Cancer Society, the National Cancer Institute, the CDC Foundation’s Bloomberg Initiative to Reduce Tobacco Use, the Asia Pacific Quitline Network, and the University of Washington Tobacco Studies Program.